Recall of Blemish Spot Treatment Due to Stability Issues
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Island Kinetics, Inc. is voluntarily recalling 28,163 bottles of Blemish Spot Treatment because they failed stability specifications, affecting products distributed nationwide in the United States.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 3, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
The recall was initiated due to the product failing stability specifications.
Which Products Are Affected
The affected products are Blemish Spot Treatment (Salicylic Acid) 1%, 0.5 fl oz (15 ml) bottles, manufactured by Skin Script in Chandler, AZ 85226, with UPC 6 10563 13873 9. A total of 28,163 bottles are involved, specifically lots 4228D2 and 4229D1 with expiration date 07/31/2026, and lot 5147D2 with expiration date 04/30/2027. These products were distributed nationwide in the United States.
What You Should Do
Consumers should contact the recalling firm, Island Kinetics, Inc. d.b.a. CoValence Laboratories, at their address: 460 S Benson Ln Ste 1-3, Chandler, AZ 85224-5663, for instructions on returns or refunds, as the recall was initiated via letter.
Why This Matters
This recall affects over 28,000 bottles of a drug product distributed across the U.S., potentially impacting product quality and consumer safety due to stability failures.
Source
Information from the FDA recall notice: Recall Number D-0487-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,057 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to May 3, 2026.
Frequently Asked Questions
Common questions about this FDA recall.